Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer
| Class:Id | LiteratureReference:9711850 |
|---|
| _displayName | Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer |
|---|
| _timestamp | 2021-01-13 21:48:15 |
|---|
| author | [Person:9711841] Kelly, Lindsey M
[Person:9711807] Barila, Guillermo
[Person:9711809] Liu, Pengyuan
[Person:9711798] Evdokimova, Viktoria N
[Person:9711834] Trivedi, Sumita
[Person:9711868] Panebianco, Federica
[Person:6801920] Gandhi, Manoj
[Person:9711857] Carty, Sally E
[Person:9711855] Hodak, Steven P
[Person:9711800] Luo, Jianhua
[Person:9711802] Dacic, Sanja
[Person:9711899] Yu, Yan P
[Person:6802070] Nikiforova, Marina N
[Person:9711784] Ferris, Robert L
[Person:9660396] Altschuler, Daniel L
[Person:5657771] Nikiforov, Yuri E |
|---|
| created | [InstanceEdit:9711838] Rothfels, Karen, 2021-01-13 |
|---|
| journal | Proc Natl Acad Sci U S A |
|---|
| pages | 4233-8 |
|---|
| pubMedIdentifier | 24613930 |
|---|
| title | Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer |
|---|
| volume | 111 |
|---|
| year | 2014 |
|---|
| (literatureReference) | [CandidateSet:9700080] ALK fusion proteins [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:9700485] STRN(1-137)-ALK(1058-1620) fusion [cytosol] [Homo sapiens]
[DefinedSet:9700529] crizotinib-sensitive ALK mutants [cytosol] [Homo sapiens]
[Reaction:9700131] ALK mutants bind type I TKIs [Homo sapiens]
[Reaction:9700179] Ligand-independent dimerization of ALK fusions [Homo sapiens] |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer (9711850)
